JP2008547025A5 - - Google Patents

Download PDF

Info

Publication number
JP2008547025A5
JP2008547025A5 JP2008518376A JP2008518376A JP2008547025A5 JP 2008547025 A5 JP2008547025 A5 JP 2008547025A5 JP 2008518376 A JP2008518376 A JP 2008518376A JP 2008518376 A JP2008518376 A JP 2008518376A JP 2008547025 A5 JP2008547025 A5 JP 2008547025A5
Authority
JP
Japan
Prior art keywords
ciphergen
group
analyzed
manufactured
ovarian cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008518376A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008547025A (ja
JP5159619B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/024269 external-priority patent/WO2007002264A2/en
Publication of JP2008547025A publication Critical patent/JP2008547025A/ja
Publication of JP2008547025A5 publication Critical patent/JP2008547025A5/ja
Application granted granted Critical
Publication of JP5159619B2 publication Critical patent/JP5159619B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008518376A 2005-06-22 2006-06-21 卵巣癌のバイオマーカー：ｃｔａｐ３関連タンパク質 Active JP5159619B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69332405P 2005-06-22 2005-06-22
US60/693,324 2005-06-22
PCT/US2006/024269 WO2007002264A2 (en) 2005-06-22 2006-06-21 Biomarker for ovarian cancer: ctap3-related proteins

Publications (3)

Publication Number Publication Date
JP2008547025A JP2008547025A (ja) 2008-12-25
JP2008547025A5 true JP2008547025A5 (https=) 2009-07-16
JP5159619B2 JP5159619B2 (ja) 2013-03-06

Family

ID=37595819

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008518376A Active JP5159619B2 (ja) 2005-06-22 2006-06-21 卵巣癌のバイオマーカー：ｃｔａｐ３関連タンパク質

Country Status (10)

Country Link
US (5) US20070172902A1 (https=)
EP (1) EP1907841B1 (https=)
JP (1) JP5159619B2 (https=)
CN (2) CN105823877B (https=)
AT (1) ATE438856T1 (https=)
AU (1) AU2006262182B2 (https=)
CA (1) CA2611340A1 (https=)
DE (1) DE602006008310D1 (https=)
IL (3) IL187867A (https=)
WO (1) WO2007002264A2 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8068990B2 (en) 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
EP1877795A4 (en) * 2005-05-02 2010-04-28 Brigham & Womens Hospital DIAGNOSTIC PROFILE MANUFACTURE OF SERUM ANTIBODIES
CN101473041B (zh) * 2006-01-04 2017-11-14 富士瑞必欧美国公司 He4与其它生化标记物在评估子宫内膜癌和子宫癌中的应用
WO2008048508A2 (en) * 2006-10-13 2008-04-24 Vermillion, Inc. Prognostic biomarkers in patients with ovarian cancer
JP5238171B2 (ja) * 2007-03-14 2013-07-17 株式会社東芝 光導波路型抗体チップ
US8221984B2 (en) 2007-03-27 2012-07-17 Vermillion, Inc. Biomarkers for ovarian cancer
KR100997463B1 (ko) 2007-04-30 2010-11-30 (주)예비티 난소암 진단용 조성물, 그 키트 및 진단 방법
US8664358B2 (en) * 2007-06-29 2014-03-04 Vermillion, Inc. Predictive markers for ovarian cancer
WO2009058331A2 (en) * 2007-10-29 2009-05-07 Vermilllion, Inc. Biomarkers for the detection of early stage ovarian cancer
US8642347B2 (en) * 2008-01-31 2014-02-04 The Brigham And Women's Hospital, Inc. Urinary CA125 peptides as biomarkers of ovarian cancer
CA2718251A1 (en) 2008-03-10 2009-09-17 Lineagen, Inc. Copd biomarker signatures
US8476026B2 (en) * 2008-04-01 2013-07-02 The Brigham And Women's Hospital, Inc. Biomarkers of ovarian cancer
US20120004854A1 (en) * 2008-05-28 2012-01-05 Georgia Tech Research Corporation Metabolic biomarkers for ovarian cancer and methods of use thereof
JP5422785B2 (ja) * 2008-09-12 2014-02-19 国立大学法人名古屋大学 質量分析法を利用した複数癌腫の血液検出のための方法および生物マーカー
EP2273272A1 (en) 2009-07-06 2011-01-12 Stichting Katholieke Universiteit Method for predicting the outcome of chemotherapy in ovarian cancer
JP6076901B2 (ja) * 2010-07-16 2017-02-15 スティヒティング フェーユーエムセー 被験者の血液サンプル中の疾患マーカーの存在の分析方法
CN102375063A (zh) * 2010-08-23 2012-03-14 湖州赛尔迪生物医药科技有限公司 一种常见蛋白质的免疫质谱试剂盒及制备方法
JP5686431B2 (ja) * 2011-01-28 2015-03-18 学校法人 京都産業大学 卵巣癌の検出方法、並びに、キット
US20140024552A1 (en) * 2011-02-15 2014-01-23 The Johns Hopkins University Compositions and methods for diagnosing ovarian cancer
CA2830461C (en) * 2011-03-18 2021-06-29 Thomas Wurdinger A method of analysing a blood sample of a subject for the presence of a disease marker
WO2013016700A1 (en) * 2011-07-27 2013-01-31 The Research Foundation Of State University Of New York Methods for generating predictive models for epithelial ovarian cancer and methods for identifying eoc
US20130196350A1 (en) * 2012-01-31 2013-08-01 Bio-Rad Laboratories, Inc. Sensitivity and specificity for ovarian cancer
WO2014144627A1 (en) 2013-03-15 2014-09-18 Abbott Laboratories Automated diagnostic analyzers having rear accessible track systems and related methods
JP6351703B2 (ja) 2013-03-15 2018-07-04 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 垂直配置カルーセルを有する自動診断分析装置および関連方法
CA2914918C (en) * 2013-05-10 2023-10-10 Johns Hopkins University Compositions and methods for ovarian cancer assessment having improved specificity
US20150126384A1 (en) * 2013-11-06 2015-05-07 Vermillion, Inc. Prognostic Biomarkers in Patients with Ovarian Cancer
CN105821030A (zh) * 2015-01-04 2016-08-03 彭霞 表达α1，3半乳糖转移酶的癌细胞/树突状细胞融合肿瘤疫苗及其制备方法
CN105821029A (zh) * 2015-01-04 2016-08-03 彭霞 异源融合基因修饰的癌细胞/树突状细胞融合肿瘤疫苗及其制备方法
WO2020218465A1 (ja) * 2019-04-26 2020-10-29 中外製薬株式会社 子宮内膜症の診断方法、病態モニタリング方法及びキット
JP7443815B2 (ja) * 2020-02-25 2024-03-06 東ソー株式会社 統計的手法によるクロマトグラムの分類方法
AU2021409465A1 (en) 2020-12-21 2023-08-03 Freenome Holdings, Inc. Markers for the early detection of colon cell proliferative disorders
WO2025237351A1 (zh) * 2024-05-16 2025-11-20 上海施江生物科技有限公司 一种磷类化合物在抗肿瘤方面中的用途

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0192738A4 (en) 1984-08-29 1987-06-25 Chiron Corp EXPRESSION OF HUMAN CONJUNCTIVE TISSUE ACTIVATOR AND RELATED PEPTIDES.
US4921790A (en) * 1987-04-24 1990-05-01 Research Corporation Tumor specific assay for CA125 ovarian cancer antigen
US5366866A (en) 1991-07-25 1994-11-22 Duke University Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies OXA and OXB
AU3332193A (en) * 1991-12-30 1993-07-28 Georgetown University Measurement of mdgf1 and its receptor as prognostic variables in breast cancer
EP0677106A4 (en) * 1993-01-07 1998-12-09 Univ South Florida GROWTH FACTORS MADE OF LEUKOCYTEN.
EP0708838A1 (en) * 1993-07-29 1996-05-01 PHARMACIA & UPJOHN COMPANY Use of heparanase to identify and isolate anti-heparanase compound
US5744585A (en) * 1995-03-16 1998-04-28 Medenica; Rajko D. Human monoclonal antibody against lung carcinoma
US20020164818A1 (en) * 1995-05-23 2002-11-07 Gruber Karl F. Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
US6491906B1 (en) * 1995-06-01 2002-12-10 The Regents Of The University Of Michigan CXC chemokines as regulators of angiogenesis
US5871723A (en) * 1995-06-06 1999-02-16 The Regent Of The University Of Michigan CXC chemokines as regulators of angiogenesis
GB9805877D0 (en) * 1998-03-20 1998-05-13 Imp Cancer Res Tech Cancer
EP1145541B1 (en) * 1998-11-24 2012-11-21 Niksun, Inc. Apparatus and method for collecting and analyzing communications data
US6683881B1 (en) * 1999-05-28 2004-01-27 Ericsson Inc. Interface between an SS7 gateway and an IP network
US7058973B1 (en) * 2000-03-03 2006-06-06 Symantec Corporation Network address translation gateway for local area networks using local IP addresses and non-translatable port addresses
US7111076B2 (en) * 2000-04-13 2006-09-19 Intel Corporation System using transform template and XML document type definition for transforming message and its reply
US20020107951A1 (en) * 2000-09-11 2002-08-08 William Teague Report group management
US20020114274A1 (en) * 2000-09-19 2002-08-22 Sturges James H. Packet based network for supporting real time applications
US20030026268A1 (en) * 2000-11-28 2003-02-06 Siemens Technology-To-Business Center, Llc Characteristic routing
US7882555B2 (en) * 2001-03-16 2011-02-01 Kavado, Inc. Application layer security method and system
US20050107586A1 (en) * 2001-07-31 2005-05-19 Su Eric W. Lp354 Mammalian secreted protein
US7270960B2 (en) * 2001-08-29 2007-09-18 Pacific Northwest Research Institute Diagnosis of ovarian carcinomas
US7146403B2 (en) * 2001-11-02 2006-12-05 Juniper Networks, Inc. Dual authentication of a requestor using a mail server and an authentication server
US7442512B2 (en) * 2001-11-30 2008-10-28 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7428597B2 (en) * 2002-03-28 2008-09-23 Sap Ag Content-based routing system and method
US7206862B2 (en) * 2002-04-24 2007-04-17 Microsoft Corporation Method and apparatus for efficiently matching responses to requests previously passed by a network node
NZ562192A (en) * 2002-08-06 2009-07-31 Ciphergen Biosystems Inc Use of biomarkers for detecting ovarian cancer
US7280559B2 (en) * 2002-08-16 2007-10-09 Mitsubishi Electric Research Laboratories, Inc. Distributed application layer protocol converter for communications network
US7321556B1 (en) * 2002-10-28 2008-01-22 Ipolicy Networks, Inc Application prioritization policy engine
US20040128360A1 (en) * 2002-12-31 2004-07-01 Robert Petri Channel server
US7895589B2 (en) * 2003-02-26 2011-02-22 International Business Machines Corporation Dynamic data-driven application integration adapters
US6898632B2 (en) * 2003-03-31 2005-05-24 Finisar Corporation Network security tap for use with intrusion detection system
US8027922B2 (en) * 2003-07-14 2011-09-27 Sprint Communications Company L.P. Integration infrastructure
JP2005057435A (ja) * 2003-08-01 2005-03-03 Sony Corp クライアント機器及びクライアント機器におけるコンテンツ処理方法、並びにコンテンツ提供システム
JP2007504463A (ja) * 2003-09-05 2007-03-01 ロイヤル ウィメンズ ホスピタル 卵巣癌用の診断マーカー
US20070178458A1 (en) * 2003-09-05 2007-08-02 O'brien Philippa Methods of diagnosis and prognosis of ovarian cancer II
AU2005236075A1 (en) * 2004-04-26 2005-11-03 Children's Medical Center Corporation Platelet biomarkers for the detection of disease
US20050289538A1 (en) * 2004-06-23 2005-12-29 International Business Machines Corporation Deploying an application software on a virtual deployment target
EP1766408A2 (en) * 2004-07-09 2007-03-28 Tripath Imaging, Inc. Methods and compositions for the detection of ovarian cancer
EP2848942B1 (en) * 2004-07-14 2017-03-08 The Regents of The University of California Biomarkers for early detection of ovarian cancer
MX2007001357A (es) * 2004-08-02 2009-08-07 Childrens Medical Center Biomarcadores de plaquetas para cancer.
AU2006223374B2 (en) * 2005-03-11 2011-07-21 Aspira Women’s Health Inc. Biomarkers for ovarian cancer and endometrial cancer: hepcidin
US7483429B2 (en) * 2005-05-18 2009-01-27 International Business Machines Corporation Method and system for flexible network processor scheduler and data flow

Similar Documents

Publication Publication Date Title
JP2008547025A5 (https=)
Jager et al. In-depth plasma N-glycoproteome profiling using narrow-window data-independent acquisition on the Orbitrap Astral mass spectrometer
Villar et al. Proteomics and cancer research
Snel et al. P112-S Increased Selectivity for the Ion Mapping of Synthetic and Endogenous Small Molecules from Tissue Sections using MS/MS on a MALDI Q-Tof Mass Spectrometer
Ruddat et al. P179-M A Verification of Novel Experimental Design for Comparative Two-Dimensional Gel Analysis: Pre-Labeled Samples Fractionated on Anion Exchange Column Followed by 2D DIGE
Parman et al. P207-T protein identification and quantitative analysis of complex mixtures using a peptide-based isobaric mass tagging technology
Champion et al. P194-M Quantification of Protein Substrates From M. Tuberculosis Culture Supernatants Reveals Alternative Conserved Pathways for Virulence Factor Secretion
Eigenheer Jr et al. P156-T An in Vivo Extracellular Proteomic Study of the Human Fungal Pathogen Cryptococcus Neoformans
Zhang et al. P193-S A Combined PTM Discovery Workflow as a Powerful Tool for Identification of Tyrosine Phosphorylation in GeLC-MS/MS Analysis
Holbrook et al. P223-S A Tale of Two Technologies: From Slab Gel to Capillary, Updating the Biomolecular Core Laboratory Genotyping Unit
Wang et al. P130-S Development and Evaluation of an Absolute qPCR Technique for Methicillin-Resistant Staphylococcus aureus (MRSA) in Ventilator Associated Pneumonia (VAP) by using Mini-bronchoalveolar Lavage (mini-BAL) Specimens
Conaway et al. P108-T Distribution of Tarceva in Pancreatic Tumors by Imaging Mass Spectrometry Using a Finnigan LTQ Linear Ion Trap Mass Spectrometer with vMALDI Source
Starosta et al. P184-S Proteomic Studies of Lipoxin A4–Induced Inhibition of Granulocyte-Macrophage Colony Stimulating Factor Signaling
Lee et al. P165-T Mass Spectrometric Identification of Proteins of the Ureaplasma Urealyticum Using a 2D Chromatographic Protein Fractionation System
Lazarev et al. P164-M Optimization of the Gel Shredder: A Centrifugal Device for Automated In-gel Digestion with Improved Peptide Recovery
Martyniuk et al. P205-S A Novel Toxicological LC MS/MS Application to Measure Biomarker Proteins in Largemouth Bass
Friedman et al. P199-S Assessing Signal to Noise in Quantitative Proteomics
Valaskovic et al. P113-M Voltage/Current Divider Effects on Nanoelectrospray Threshold Voltage and Electrospray Stability
Yang et al. P192-T On-Slide Chemical Modification as a Means to Improve Confidence in Protein Identifications Made by Peptide Mass Fingerprints
McKenna et al. P144-T Top Down Sequence Analysis of Intact Protein Species Using a Novel Travelling Wave Ion Mobility Device Coupled With a Time-of-Flight Mass Spectrometer
Peter et al. P175-S Enrichment and Detection of Molecules Secreted by Tumor Cells Using Magnetic Reversed Phase Particles and LC-MALDI-TOF-MS
Langridge et al. P115A-T High Speed Nanoscale UPLC Separations Combined with Off-Line MALDI MS/MS for Peptide Analysis
Steinke et al. P210-T Comparative Environmental Proteomics of Different Temperature Areas in Octopus Hot Spring, Yellowstone National Park
Schweiger-Hufnagel et al. P209-M Non-Isobaric Triplex-Labeling Strategies for Proteomics
Fisher et al. P225-T Influence of Sample-Loading Solutions on Sequencing Performance and Loss of Resolution on the Applied Biosystems 3730 DNA Analyzer